Beslut om trombosprofylax vid graviditet--enklare med riskpoäng
(2006) In Läkartidningen 103(18). p.1429-1432- Abstract
- Swedish guidelines for thrombosis risk estimation and thrombosis prophylaxis in relation to pregnancy are based on risk factors with a 5-fold increased risk of thrombosis or some multiple thereof. The risk factors are added together forming a risk score, where by risk score 1 is associated with a 5-fold increased risk, risk score 2 with a 25-fold increased risk, etc. The absolute risk of thrombosis in women with a risk score of 4 is estimated to be approximately 10%. Women with a risk score of 2 are recommended to undergo a short term postpartum prophylaxis (7 days), risk score 3 should be given 6 weeks of postpartum prophylaxis, and those with a risk score of > 4, both antepartum prophylaxis and 6 weeks of postpartum prophylaxis. A... (More)
- Swedish guidelines for thrombosis risk estimation and thrombosis prophylaxis in relation to pregnancy are based on risk factors with a 5-fold increased risk of thrombosis or some multiple thereof. The risk factors are added together forming a risk score, where by risk score 1 is associated with a 5-fold increased risk, risk score 2 with a 25-fold increased risk, etc. The absolute risk of thrombosis in women with a risk score of 4 is estimated to be approximately 10%. Women with a risk score of 2 are recommended to undergo a short term postpartum prophylaxis (7 days), risk score 3 should be given 6 weeks of postpartum prophylaxis, and those with a risk score of > 4, both antepartum prophylaxis and 6 weeks of postpartum prophylaxis. A small group has been classified as “very high risk” and is not included in the scoring system. Low molecular weight heparin is recommended for thrombosis prophylaxis, due to its favorable safety and effect profile. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1135517
- author
- Lindqvist, Pelle LU ; Hellgren, Margareta ; Nord, Eva and Nyman, Margareta
- organization
- alternative title
- Thrombosis prophylaxis decisions in pregnancy--simpler with risk scores
- publishing date
- 2006
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Barnsängssjukdomar, Graviditetskomplikationer, Blodförtunningsmedel, Fibrinolytika, Ventrombos, hjärta-kärl
- in
- Läkartidningen
- volume
- 103
- issue
- 18
- pages
- 1429 - 1432
- publisher
- Swedish Medical Association
- external identifiers
-
- pmid:16729455
- scopus:33646688659
- ISSN
- 0023-7205
- language
- Swedish
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pediatrics/Urology/Gynecology/Endocrinology (013240400)
- id
- 77ecf9d3-9cae-4a12-8042-a101dd8e5c01 (old id 1135517)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16729455&dopt=Abstract
- http://ltarkiv.lakartidningen.se/2006/temp/pda31747.pdf
- date added to LUP
- 2016-04-01 17:01:01
- date last changed
- 2022-01-28 23:44:49
@article{77ecf9d3-9cae-4a12-8042-a101dd8e5c01,
abstract = {{Swedish guidelines for thrombosis risk estimation and thrombosis prophylaxis in relation to pregnancy are based on risk factors with a 5-fold increased risk of thrombosis or some multiple thereof. The risk factors are added together forming a risk score, where by risk score 1 is associated with a 5-fold increased risk, risk score 2 with a 25-fold increased risk, etc. The absolute risk of thrombosis in women with a risk score of 4 is estimated to be approximately 10%. Women with a risk score of 2 are recommended to undergo a short term postpartum prophylaxis (7 days), risk score 3 should be given 6 weeks of postpartum prophylaxis, and those with a risk score of > 4, both antepartum prophylaxis and 6 weeks of postpartum prophylaxis. A small group has been classified as “very high risk” and is not included in the scoring system. Low molecular weight heparin is recommended for thrombosis prophylaxis, due to its favorable safety and effect profile.}},
author = {{Lindqvist, Pelle and Hellgren, Margareta and Nord, Eva and Nyman, Margareta}},
issn = {{0023-7205}},
keywords = {{Barnsängssjukdomar; Graviditetskomplikationer; Blodförtunningsmedel; Fibrinolytika; Ventrombos; hjärta-kärl}},
language = {{swe}},
number = {{18}},
pages = {{1429--1432}},
publisher = {{Swedish Medical Association}},
series = {{Läkartidningen}},
title = {{Beslut om trombosprofylax vid graviditet--enklare med riskpoäng}},
url = {{http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16729455&dopt=Abstract}},
volume = {{103}},
year = {{2006}},
}